Current projects

Go-to-market of 2nd-generation Alzheimer mouse model

reMYND’s CRO helps its clients assess in-vivo characteristics, pharmacokinetics/dynamics and the effects of their experimental treatments against Alzheimer’s disease (AD) in reMYND’s proprietary Alzheimer mouse models.

Open for a new project

We help innovative companies and their supportive ecosystem starting up or stepping up their project, program, business, partnership and/or client development and management – not by talking but by doing: hands-on & in-residence. Focus areas: medical biotech & digital health. Don’t hesitate to contact us!